col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Frontiers Media SA: Frontiers in Pharmacology
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―20 Corrigendum: Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective Alfred Francis Attah, Adeshola Adebayo Fagbemi, Olujide Olubiyi, Hannah Dada-Adegbola, Akinseinde Oluwadotun, Anthony Elujoba, Chinedum Peace Babalola
2 [GO] 2021―Jul―20 Medicinal Plants Used for Treating Mild Covid-19 Symptoms Among Thai Karen and Hmong Methee Phumthum, Varangrat Nguanchoo, Henrik Balslev
3 [GO] 2021―Jul―16 The Role of High-Density Lipoprotein in COVID-19 Guyi Wang, Jiayi Deng, Jinxiu Li, Chenfang Wu, Haiyun Dong, Shangjie Wu, Yanjun Zhong
4 [GO] 2021―Jul―16 Potentials of Antitussive Traditional Persian Functional Foods for COVID-19 Therapy† Ghazaleh Mosleh, Parmis Badr, Meysam Zaeri, Abdolali Mohagheghzadeh
5 [GO] 2021―Jul―15 Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review Zhi-Hua Yang, Bin Wang, Qian Ma, Lin Wang, Ya-Xin Lin, Hai-Feng Yan, et al. (+8)
6 [GO] 2021―Jul―09 Glycyrrhizic Acid: A Natural Plant Ingredient as a Drug Candidate to Treat COVID-19 Zhong Sun, Guozhong He, Ninghao Huang, Karuppiah Thilakavathy, Jonathan Chee Woei Lim, S. Suresh Kumar, Chenglong Xiong
7 [GO] 2021―Jul―08 Exploring Phytochemicals of Traditional Medicinal Plants Exhibiting Inhibitory Activity Against Main Protease, Spike Glycoprotein, RNA-dependent RNA Polymerase and Non-Structural Proteins of SARS-CoV-2 Through Virtual Screening Saranya Nallusamy, Jayakanthan Mannu, Caroline Ravikumar, Kandavelmani Angamuthu, Bharathi Nathan, Kumaravadivel Nachimuthu, et al. (+4)
8 [GO] 2021―Jul―07 Herbal Medicine, Gut Microbiota, and COVID-19 Ziqi Chen, Yiwen Lv, Huachong Xu, Li Deng
9 [GO] 2021―Jul―07 Remdesivir Strongly Binds to RNA-Dependent RNA Polymerase, Membrane Protein, and Main Protease of SARS-CoV-2: Indication From Molecular Modeling and Simulations Faez Iqbal Khan, Tongzhou Kang, Haider Ali, Dakun Lai
10 [GO] 2021―Jul―05 Targeting SARS-CoV-2-Platelet Interactions in COVID-19 and Vaccine-Related Thrombosis Dermot Cox
11 [GO] 2021―Jul―02 Efficacy and Safety of Leflunomide for Refractory COVID-19: A Pilot Study Qiang Wang, Haipeng Guo, Yu Li, Xiangdong Jian, Xinguo Hou, Ning Zhong, et al. (+14)
12 [GO] 2021―Jul―01 High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19 Mario Karolyi, Sara Omid, Erich Pawelka, Bernd Jilma, Thomas Stimpfl, Christian Schoergenhofer, et al. (+5)
13 [GO] 2021―Jul―01 Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment Luis Sarabia De Ardanaz, Jose M. Andreu-Ubero, Miriam Navidad-Fuentes, Miguel Ángel Ferrer-González, Victor Ruíz del Valle, Inmaculada Salcedo-Bellido, et al. (+3)
14 [GO] 2021―Jun―29 The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19 Shengguang Wang, Zhen Li, Xinyu Wang, Shiming Zhang, Peng Gao, Zuorong Shi
15 [GO] 2021―Jun―29 Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection Seyed Abdulmajid Ayatollahi, Javad Sharifi-Rad, Patrick Valere Tsouh Fokou, Gail B. Mahady, Hafiz Ansar Rasul Suleria, Shivani Krishna Kapuganti, et al. (+9)
16 [GO] 2021―Jun―24 Serratiopeptidase, A Serine Protease Anti-Inflammatory, Fibrinolytic, and Mucolytic Drug, Can Be a Useful Adjuvant for Management in COVID-19 Charu Sharma, Niraj Kumar Jha, M. F. Nagoor Meeran, Chandragouda R. Patil, Sameer N. Goyal, Shreesh Ojha
17 [GO] 2021―Jun―23 Prevention and Recovery of COVID-19 Patients With Kampo Medicine: Review of Case Reports and Ongoing Clinical Trials Shin Takayama, Takao Namiki, Hiroshi Odaguchi, Ryutaro Arita, Akito Hisanaga, Kazuo Mitani, Takashi Ito
18 [GO] 2021―Jun―21 Overview of Viral Pneumonia Associated With Influenza Virus, Respiratory Syncytial Virus, and Coronavirus, and Therapeutics Based on Natural Products of Medicinal Plants Ziwei Hu, Jinhong Lin, Jintao Chen, Tengxi Cai, Lixin Xia, Ying Liu, et al. (+2)
19 [GO] 2021―Jun―18 He-Jie-Shen-Shi Decoction as an Adjuvant Therapy on Severe Coronavirus Disease 2019: A Retrospective Cohort and Potential Mechanistic Study Haibo Hu, Kun Wang, Li Wang, Yanjun Du, Juan Chen, Yongchun Li, et al. (+7)
20 [GO] 2021―Jun―17 The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19 M. Ekholm, T. Kahan
21 [GO] 2021―Jun―17 Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation Ting Xiao, Mengqi Cui, Caijuan Zheng, Ming Wang, Ronghao Sun, Dandi Gao, et al. (+8)
22 [GO] 2021―Jun―16 Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences Elena Campione, Caterina Lanna, Terenzio Cosio, Luigi Rosa, Maria Pia Conte, Federico Iacovelli, et al. (+25)
23 [GO] 2021―Jun―14 A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2 Kaleb B. Tsegay, Christiana M. Adeyemi, Edward P. Gniffke, D. Noah Sather, John K. Walker, Stephen E. P. Smith
24 [GO] 2021―Jun―14 Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021 Safaet Alam, Taslima Binte Kamal, Md. Moklesur Rahman Sarker, Jin-Rong Zhou, S. M. Abdur Rahman, Isa Naina Mohamed
25 [GO] 2021―Jun―11 A Dual-Route Perspective of SARS-CoV-2 Infection: Lung- vs. Gut-specific Effects of ACE-2 Deficiency Elizabeth M. Sajdel-Sulkowska
26 [GO] 2021―Jun―10 Glycyrrhizic Acid for COVID-19: Findings of Targeting Pivotal Inflammatory Pathways Triggered by SARS-CoV-2 Wenjiang Zheng, Xiufang Huang, Yanni Lai, Xiaohong Liu, Yong Jiang, Shaofeng Zhan
27 [GO] 2021―Jun―07 Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19 Clarissa S. Santoso, Zhaorong Li, Jaice T. Rottenberg, Xing Liu, Vivian X. Shen, Juan I. Fuxman Bass
28 [GO] 2021―Jun―07 A Cross-Sectional Survey on Medication Management Practices for Noncommunicable Diseases in Europe During the Second Wave of the COVID-19 Pandemic Tamás Ágh, Job FM van Boven, Björn Wettermark, Enrica Menditto, Hilary Pinnock, Ioanna Tsiligianni, et al. (+4)
29 [GO] 2021―Jun―07 Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential Xinyu Cui, Wuyue Chen, Haoyan Zhou, Yuan Gong, Bowen Zhu, Xiang Lv, et al. (+5)
30 [GO] 2021―Jun―04 The Role of Regional Anesthesia During the SARS-CoV2 Pandemic: Appraisal of Clinical, Pharmacological and Organizational Aspects Gianluca Cappelleri, Andrea Fanelli, Daniela Ghisi, Gianluca Russo, Antonio Giorgi, Vito Torrano, et al. (+3)
31 [GO] 2021―Jun―03 Adverse Effects Associated With the Use of Antimalarials During The COVID-19 Pandemic in a Tertiary Care Center in Mexico City Oscar Arturo Lozano-Cruz, José Víctor Jiménez, Antonio Olivas-Martinez, Edgar Ortiz-Brizuela, José Luis Cárdenas-Fragoso, Daniel Azamar-Llamas, et al. (+13)
32 [GO] 2021―May―28 Oral Curcumin With Piperine as Adjuvant Therapy for the Treatment of COVID-19: A Randomized Clinical Trial Kirti S Pawar, Rahul N Mastud, Satheesh K Pawar, Samragni S Pawar, Rahul R Bhoite, Ramesh R Bhoite, et al. (+2)
33 [GO] 2021―May―28 Traditional Herbal Medicines, Bioactive Metabolites, and Plant Products Against COVID-19: Update on Clinical Trials and Mechanism of Actions Safaet Alam, Md. Moklesur Rahman Sarker, Sadia Afrin, Fahmida Tasnim Richi, Chao Zhao, Jin-Rong Zhou, Isa Naina Mohamed
34 [GO] 2021―May―26 The Therapeutic Effect of Traditional Chinese Medicine on Inflammatory Diseases Caused by Virus, Especially on Those Caused by COVID-19 Peng Li, Shuang Hu, Cheng Qian, Yan Yao, Liang-yun Li, Jun-fa Yang, et al. (+10)
35 [GO] 2021―May―26 Systemic Corticosteroid Administration in Coronavirus Disease 2019 Outcomes: An Umbrella Meta-Analysis Incorporating Both Mild and Pulmonary Fibrosis-Manifested Severe Disease Bin Cheng, Jinxiu Ma, Yani Yang, Tingting Shao, Binghao Zhao, Linxiang Zeng
36 [GO] 2021―May―25 COVID-19-Associated Pneumonia: Radiobiological Insights Sabine François, Carole Helissey, Sophie Cavallero, Michel Drouet, Nicolas Libert, Jean-Marc Cosset, et al. (+3)
37 [GO] 2021―May―20 A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients Alain Bousquet-Mélou, Anne Lespine, Jean-François Sutra, Isabelle Bargues, Pierre-Louis Toutain
38 [GO] 2021―May―14 β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19 Niraj Kumar Jha, Charu Sharma, Hebaallah Mamdouh Hashiesh, Seenipandi Arunachalam, MF Nagoor Meeran, Hayate Javed, et al. (+3)
39 [GO] 2021―May―14 Broad Anti-Viral Capacities of Lian-Hua-Qing-Wen Capsule and Jin-Hua-Qing-Gan Granule and Rational use Against COVID-19 Based on Literature Mining Mingfei Shi, Bo Peng, An Li, Ziyun Li, Ping Song, Jing Li, et al. (+2)
40 [GO] 2021―May―13 Synergy Between Vitamin D and Sex Hormones in Respiratory Functionality of Patients Affected by COVID-19 Daniela Peruzzu, Maria Teresa Pagano, Marina Pierdominici, Anna Ruggieri, Andrea Antinori, Gianpiero D’Offizi, et al. (+11)
41 [GO] 2021―May―12 Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19 Rachana Singh, Pradhyumna Kumar Singh, Rajnish Kumar, Md. Tanvir Kabir, Mohammad Amjad Kamal, Abdur Rauf, et al. (+5)
42 [GO] 2021―May―07 Curcumin as a Potential Treatment for COVID-19 Bruna A. C. Rattis, Simone G. Ramos, Mara R. N. Celes
43 [GO] 2021―May―07 The Anti-Viral and Anti-Inflammatory Properties of Edible Bird’s Nest in Influenza and Coronavirus Infections: From Pre-Clinical to Potential Clinical Application Kien Hui Chua, Isa Naina Mohamed, Mohd Heikal Mohd Yunus, Norefrina Shafinaz Md Nor, Khidhir Kamil, Azizah Ugusman, Jaya Kumar
44 [GO] 2021―May―06 The Rise and Fall of Chloroquine/Hydroxychloroquine as Compassionate Therapy of COVID-19 Elangovan Manivannan, Chandrabose Karthikeyan, N. S. Hari Narayana Moorthy, Subash Chandra Chaturvedi
45 [GO] 2021―May―03 Withania somnifera (L.) Dunal: Opportunity for Clinical Repurposing in COVID-19 Management Akash Saggam, Kirti Limgaokar, Swapnil Borse, Preeti Chavan-Gautam, Santosh Dixit, Girish Tillu, Bhushan Patwardhan
46 [GO] 2021―May―03 A Survey Among Italian Physicians During COVID-19 Outbreak. Could Bacillus Calmette-Guérin Vaccine Be Effective Against SARS-CoV2? Vincenzo Patella, Alessandro Sanduzzi, Dario Bruzzese, Giovanni Florio, Raffaele Brancaccio, Gabriella Fabbrocini, Gabriele Delfino
47 [GO] 2021―May―03 Natural Products Modulating Angiotensin Converting Enzyme 2 (ACE2) as Potential COVID-19 Therapies Murtala Bello Abubakar, Dawoud Usman, Gaber El-Saber Batiha, Natália Cruz-Martins, Ibrahim Malami, Kasimu Ghandi Ibrahim, et al. (+10)
48 [GO] 2021―May―03 Comparative Effectiveness of Pharmacological Interventions for Covid-19: A Systematic Review and Network Meta-Analysis Franco De Crescenzo, Laura Amato, Fabio Cruciani, Luke P Moynihan, Gian Loreto D’Alò, Simona Vecchi, et al. (+5)
49 [GO] 2021―Apr―30 Intermittent Hypoxic Preconditioning: A Potential New Powerful Strategy for COVID-19 Rehabilitation Ming Cai, Xuan Chen, Jieling Shan, Ruoyu Yang, Qi Guo, Xia Bi, et al. (+4)
50 [GO] 2021―Apr―28 Edible and Herbal Plants for the Prevention and Management of COVID-19 Sha Li, Chien-Shan Cheng, Cheng Zhang, Guo-Yi Tang, Hor-Yue Tan, Hai-Yong Chen, et al. (+3)
51 [GO] 2021―Apr―26 Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective Alfred Francis Attah, Adeshola Adebayo Fagbemi, Olujide Olubiyi, Hannah Dada-Adegbola, Akinseinde Oluwadotun, Anthony Elujoba, Chinedum Peace Babalola
52 [GO] 2021―Apr―26 Phytochemicals as Potential Therapeutics for SARS-CoV-2-Induced Cardiovascular Complications: Thrombosis and Platelet Perspective Samir K. Beura, Abhishek R. Panigrahi, Pooja Yadav, Sunil K. Singh
53 [GO] 2021―Apr―23 Pleiotropic Effects of Tetracyclines in the Management of COVID-19: Emerging Perspectives Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Mohammed Alqarni, Natália Cruz-Martins, Gaber El-Saber Batiha
54 [GO] 2021―Apr―22 SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models G. Kanimozhi, B. Pradhapsingh, Charan Singh Pawar, Haseeb A. Khan, Salman H. Alrokayan, N. Rajendra Prasad
55 [GO] 2021―Apr―22 High Dose Intravenous Vitamin C for Preventing The Disease Aggravation of Moderate COVID-19 Pneumonia. A Retrospective Propensity Matched Before-After Study Bing Zhao, Min Liu, Ping Liu, Yibing Peng, Jun Huang, Mengjiao Li, et al. (+9)
56 [GO] 2021―Apr―22 No Efficacy of the Combination of Lopinavir/Ritonavir Plus Hydroxychloroquine Versus Standard of Care in Patients Hospitalized With COVID-19: A Non-Randomized Comparison Roberta Gagliardini, Alessandro Cozzi-Lepri, Andrea Mariano, Fabrizio Taglietti, Alessandra Vergori, Amina Abdeddaim, et al. (+15)
57 [GO] 2021―Apr―20 The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19 Annamaria Mascolo, Cristina Scavone, Concetta Rafaniello, Antonella De Angelis, Konrad Urbanek, Gabriella di Mauro, et al. (+4)
58 [GO] 2021―Apr―20 Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19 Vikas P. Sukhatme, Angela M. Reiersen, Sharat J. Vayttaden, Vidula V. Sukhatme
59 [GO] 2021―Apr―20 SARS-CoV-2 Switches ‘on’ MAPK and NFκB Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression Swati Goel, Fatemeh Saheb Sharif-Askari, Narjes Saheb Sharif Askari, Bushra Madkhana, Ahmad Munzer Alwaa, Bassam Mahboub, et al. (+5)
60 [GO] 2021―Apr―19 Giloy Ghanvati (Tinospora cordifolia (Willd.) Hook. f. and Thomson) Reversed SARS-CoV-2 Viral Spike-Protein Induced Disease Phenotype in the Xenotransplant Model of Humanized Zebrafish Acharya Balkrishna, Lakshmipathi Khandrika, Anurag Varshney
61 [GO] 2021―Apr―16 Na+/K+-ATPase as a Target of Cardiac Glycosides for the Treatment of SARS-CoV-2 Infection Kauê Francisco Corrêa Souza e Souza, Bianca Portugal Tavares Moraes, Izabel Christina Nunes de Palmer Paixão, Patrícia Burth, Adriana Ribeiro Silva, Cassiano Felippe Gonçalves-de-Albuquerque
62 [GO] 2021―Apr―12 Evolving Treatment Paradigm in the Management of Diabetic Macular Edema in the Era of COVID-19 Claudio Iovino, Enrico Peiretti, Giuseppe Giannaccare, Vincenzo Scorcia, Adriano Carnevali
63 [GO] 2021―Apr―12 Commentary: Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated With Coronavirus Disease-2019 Maurizio Bifulco, Donatella Fiore, Chiara Piscopo, Patrizia Gazzerro, Maria Chiara Proto
64 [GO] 2021―Apr―12 Repurposing Chloroquine Against Multiple Diseases With Special Attention to SARS-CoV-2 and Associated Toxicity Siya Kamat, Madhuree Kumari
65 [GO] 2021―Apr―12 Potential Mechanism Prediction of Herbal Medicine for Pulmonary Fibrosis Associated with SARS-CoV-2 Infection Based on Network Analysis and Molecular Docking De Jin, Xuedong An, Yuqing Zhang, Shenghui Zhao, Liyun Duan, Yingying Duan, et al. (+2)
66 [GO] 2021―Apr―12 Phytoconstituents, In Vitro Anti-Infective Activity of Buddleja indica Lam., and In Silico Evaluation of its SARS-CoV-2 Inhibitory Potential Fadia S. Youssef, Ahmed E. Altyar, Abdelsattar M. Omar, Mohamed L. Ashour
67 [GO] 2021―Apr―01 Pathological Findings in COVID-19 as a Tool to Define SARS-CoV-2 Pathogenesis. A Systematic Review Cristina Mondello, Salvatore Roccuzzo, Orazio Malfa, Daniela Sapienza, Patrizia Gualniera, Elvira Ventura Spagnolo, et al. (+4)
68 [GO] 2021―Mar―29 Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials Rodolfo Pedro Rothlin, Mariano Duarte, Facundo Germán Pelorosso, Liliana Nicolosi, M. Victoria Salgado, Héctor Miguel Vetulli, Eduardo Spitzer
69 [GO] 2021―Mar―26 Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen Jordi Rodon, Jordana Muñoz-Basagoiti, Daniel Perez-Zsolt, Marc Noguera-Julian, Roger Paredes, Lourdes Mateu, et al. (+12)
70 [GO] 2021―Mar―25 Head-to-Head Comparison of Sedation and Somnolence Among 37 Antipsychotics in Schizophrenia, Bipolar Disorder, Major Depression, Autism Spectrum Disorders, Delirium, and Repurposed in COVID-19, Infectious Diseases, and Oncology From the FAERS, 2004-2020 Andy R. Eugene, Beata Eugene, Marek Masiak, Jolanta Sylwia Masiak
71 [GO] 2021―Mar―24 Medicinal Plants in COVID-19: Potential and Limitations Xin Yi Lim, Bee Ping Teh, Terence Yew Chin Tan
72 [GO] 2021―Mar―23 COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms Robert W. Malone, Philip Tisdall, Philip Fremont-Smith, Yongfeng Liu, Xi-Ping Huang, Kris M. White, et al. (+19)
73 [GO] 2021―Mar―23 Proactive Measures to Combat a SARS-CoV-2 Transmission Among High Risk Patients and Health Care Workers in an Outpatient Dialysis Facility Jayandiran Pillai, Pagollang Motloba, Keolebogile Shirley Caroline Motaung, Carole Wallis, Lovelyn Uzoma Ozougwu, Debashis Basu
74 [GO] 2021―Mar―22 Comparing the Value of Cystatin C and Serum Creatinine for Evaluating the Renal Function and Predicting the Prognosis of COVID-19 Patients Sichao Chen, Jinpeng Li, Zeming Liu, Danyang Chen, Ling Zhou, Di Hu, et al. (+9)
75 [GO] 2021―Mar―19 Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug Fatih M. Uckun, Saran Saund, Hitesh Windlass, Vuong Trieu
76 [GO] 2021―Mar―15 Evaluation of the Current Therapeutic Approaches for COVID-19: A Systematic Review and a Meta-analysis Zeinab Abdelrahman, Qian Liu, Shanmei Jiang, Mengyuan Li, Qingrong Sun, Yue Zhang, Xiaosheng Wang
77 [GO] 2021―Mar―10 Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing Charlotte Kern, Verena Schöning, Carlos Chaccour, Felix Hammann
78 [GO] 2021―Mar―09 Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology Daniele Pala, Marco Pistis
79 [GO] 2021―Mar―09 Plant Products as Inhibitors of Coronavirus 3CL Protease Anirban Mandal, Ajeet Kumar Jha, Banasri Hazra
80 [GO] 2021―Mar―09 The Anti-inflammatory Effect of the Tricyclic Antidepressant Clomipramine and Its High Penetration in the Brain Might Be Useful to Prevent the Psychiatric Consequences of SARS-CoV-2 Infection B. Nobile, M. Durand, E. Olié, S. Guillaume, J. P. Molès, E. Haffen, P. Courtet
81 [GO] 2021―Mar―08 An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come? Omkar Indari, Shweta Jakhmola, Elangovan Manivannan, Hem Chandra Jha
82 [GO] 2021―Mar―04 1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection Rui Hong Chen, Li Jun Yang, Sami Hamdoun, Sookja Kim Chung, Christopher Wai-kei Lam, Kai Xi Zhang, et al. (+4)
83 [GO] 2021―Mar―02 Repurposing Treatment of Wernicke-Korsakoff Syndrome for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-Vitro Evidence and Pharmacokinetic Profile Vatsalya Vatsalya, Fengyuan Li, Jane Frimodig, Khushboo S. Gala, Shweta Srivastava, Maiying Kong, et al. (+4)
84 [GO] 2021―Mar―02 Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis Benedicto Crespo-Facorro, Miguel Ruiz-Veguilla, Javier Vázquez-Bourgon, Ana C. Sánchez-Hidalgo, Nathalia Garrido-Torres, Jose M. Cisneros, et al. (+2)
85 [GO] 2021―Mar―02 Indian Medicinal Plants and Formulations and Their Potential Against COVID-19-Preclinical and Clinical Research Sayeed Ahmad, Sultan Zahiruddin, Bushra Parveen, Parakh Basist, Abida Parveen, Rabea Parveen, Minhaj Ahmad
86 [GO] 2021―Mar―01 A Journey From SARS-CoV-2 to COVID-19 and Beyond: A Comprehensive Insight of Epidemiology, Diagnosis, Pathogenesis, and Overview of the Progress into Its Therapeutic Management Muhammad Harris Shoaib, Farrukh Rafiq Ahmed, Muhammad Sikandar, Rabia Ismail Yousuf, Muhammad Talha Saleem
87 [GO] 2021―Feb―26 In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19 Andrés López-Cortés, Patricia Guevara-Ramírez, Nikolaos C. Kyriakidis, Carlos Barba-Ostria, Ángela León Cáceres, Santiago Guerrero, et al. (+20)
88 [GO] 2021―Feb―26 A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review Priyanka Dash, Subhashree Mohapatra, Sayantan Ghosh, Bismita Nayak
89 [GO] 2021―Feb―26 Chinese Herbal Medicine Used With or Without Conventional Western Therapy for COVID-19: An Evidence Review of Clinical Studies Shi-Bing Liang, Ying-Ying Zhang, Chen Shen, Chang-Hao Liang, Bao-Yong Lai, Ning Dai, et al. (+9)
90 [GO] 2021―Feb―26 Discovering Potential RNA Dependent RNA Polymerase Inhibitors as Prospective Drugs Against COVID-19: An in silico Approach Satabdi Saha, Rajat Nandi, Poonam Vishwakarma, Amresh Prakash, Diwakar Kumar
91 [GO] 2021―Feb―25 Prospective: Evolution of Chinese Medicine to Treat COVID-19 Patients in China Jieya Wu, Baoguo Sun, Li Hou, Fulan Guan, Liyuan Wang, Peikwen Cheng, et al. (+3)
92 [GO] 2021―Feb―23 The Potential Therapeutic Effect of RNA Interference and Natural Products on COVID-19: A Review of the Coronaviruses Infection Mohammad Reza Kalhori, Fatemeh Saadatpour, Ehsan Arefian, Masoud Soleimani, Mohammad Hosien Farzaei, Ina Yosifova Aneva, Javier Echeverría
93 [GO] 2021―Feb―22 Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease Luca Pinzi, Annachiara Tinivella, Fabiana Caporuscio, Giulio Rastelli
94 [GO] 2021―Feb―13 Development of a Physiologically Based Pharmacokinetic Model for Hydroxychloroquine and Its Application in Dose Optimization in Specific COVID-19 Patients Miao Zhang, Xueting Yao, Zhe Hou, Xuan Guo, Siqi Tu, Zihan Lei, et al. (+10)
95 [GO] 2021―Feb―13 Molecular Mechanism of Action of Repurposed Drugs and Traditional Chinese Medicine Used for the Treatment of Patients Infected With COVID-19: A Systematic Scoping Review Fui Fui Lem, Fernandes Opook, Dexter Jiunn Herng Lee, Fong Tyng Chee, Fahcina P. Lawson, Su Na Chin
96 [GO] 2021―Feb―09 COVIEdb: A Database for Potential Immune Epitopes of Coronaviruses Jingcheng Wu, Wenfan Chen, Jingjing Zhou, Wenyi Zhao, Yisheng Sun, Hanping Zhu, et al. (+4)
97 [GO] 2021―Feb―08 Modalities and Mechanisms of Treatment for Coronavirus Disease 2019 Zhihong Zuo, Ting Wu, Liangyu Pan, Chenzhe Zuo, Yingchuo Hu, Xuan Luo, et al. (+6)
98 [GO] 2021―Feb―05 Yindan Jiedu Granules, a Traditional Chinese Medicinal Formulation, as a Potential Treatment for Coronavirus Disease 2019 Jingyuan Liu, Yuyong Jiang, Yao Liu, Lin Pu, Chunjing Du, Yuxin Li, et al. (+8)
99 [GO] 2021―Feb―05 Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro Hua-Long Xiong, Jia-Li Cao, Chen-Guang Shen, Jian Ma, Xiao-Yang Qiao, Tian-Shu Shi, et al. (+6)
100 [GO] 2021―Feb―04 Chemokine Regulation During Epidemic Coronavirus Infection Shamik Majumdar, Philip M. Murphy
101 [GO] 2021―Feb―01 Potency, Safety, and Pharmacokinetic Profiles of Potential Inhibitors Targeting SARS-CoV-2 Main Protease Hylemariam Mihiretie Mengist, Daniel Mekonnen, Ahmed Mohammed, Ronghua Shi, Tengchuan Jin
102 [GO] 2021―Jan―29 Mitochondria Are Potential Targets for the Development of New Drugs Against Neutrophilic Inflammation in Severe Pneumonia Including COVID-19 Nina V. Vorobjeva, Galina F. Sud'ina, Boris V. Chernyak
103 [GO] 2021―Jan―29 What Is the Difference Between Observed Association and Causal Association, Signals and Evidence? Examples Related to COVID-19 Vicki Osborne, Saad A. W. Shakir
104 [GO] 2021―Jan―29 HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons Andrey A. Poloznikov, Stepan A. Nersisyan, Dmitry M. Hushpulian, Eliot H. Kazakov, Alexander G. Tonevitsky, Sergey V. Kazakov, et al. (+4)
105 [GO] 2021―Jan―29 Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections Bao Sun, Shiqiong Huang, Jiecan Zhou
106 [GO] 2021―Jan―27 Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19 Angela E. Peter, B. V. Sandeep, B. Ganga Rao, V. Lakshmi Kalpana
107 [GO] 2021―Jan―26 Potential of Immune-Related Therapy in COVID-19 Chunjue Yuan, Ruoyun Li, Guohong Liu, Yunbao Pan
108 [GO] 2021―Jan―26 Commentary: Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness? Sergio Verd, Mateo Verd
109 [GO] 2021―Jan―25 Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2 Catherine Z. Chen, Paul Shinn, Zina Itkin, Richard T. Eastman, Robert Bostwick, Lynn Rasmussen, et al. (+13)
110 [GO] 2021―Jan―20 Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach Sajad Fakhri, Sana Piri, Mohammad Bagher Majnooni, Mohammad Hosein Farzaei, Javier Echeverría
111 [GO] 2021―Jan―19 Statins as Adjuvant Therapy for COVID-19 to Calm the Stormy Immunothrombosis and Beyond Alpo Vuorio, Petri T. Kovanen
112 [GO] 2021―Jan―15 Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications Israel Abebrese Sefah, Olayinka O. Ogunleye, Darius Obeng Essah, Sylvia A. Opanga, Nadia Butt, Annie Wamaitha, et al. (+20)
113 [GO] 2021―Jan―15 Utilisation, Availability and Price Changes of Medicines and Protection Equipment for COVID-19 Among Selected Regions in India: Findings and Implications Mainul Haque, Santosh Kumar, Jaykaran Charan, Rohan Bhatt, Salequl Islam, Siddhartha Dutta, et al. (+6)
114 [GO] 2021―Jan―15 TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target Gillina F. G. Bezemer, Johan Garssen
115 [GO] 2021―Jan―14 Methylene Blue Inhibits the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction-a Mechanism that can Contribute to its Antiviral Activity Against COVID-19 Damir Bojadzic, Oscar Alcazar, Peter Buchwald
116 [GO] 2021―Jan―14 3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin as a Potential Candidate Inhibits SARS-CoV-2 Infection by Disrupting the Interaction of Spike Protein With Host ACE2 Receptor Taizhen Liang, Jiayin Qiu, Xiaoge Niu, Qinhai Ma, Chenliang Zhou, Pei Chen, et al. (+5)
117 [GO] 2021―Jan―14 Tissue Distribution of ACE2 Protein in Syrian Golden Hamster (Mesocricetus auratus) and Its Possible Implications in SARS-CoV-2 Related Studies Voddu Suresh, Deepti Parida, Aliva P. Minz, Manisha Sethi, Bhabani S. Sahoo, Shantibhusan Senapati
118 [GO] 2021―Jan―11 A Review on Plant Bioactive Compounds and Their Modes of Action Against Coronavirus Infection Juwairiah Remali, Wan Mohd Aizat
119 [GO] 2021―Jan―10 The Large Action of Chlorpromazine: Translational and Transdisciplinary Considerations in the Face of COVID-19 Emmanuel Stip, Tahir A. Rizvi, Farah Mustafa, Syed Javaid, Salahdein Aburuz, Nahida Nayaz Ahmed, et al. (+5)
120 [GO] 2021―Jan―10 Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review Bruno Silva Andrade, Fernanda de Souza Rangel, Naiane Oliveira Santos, Andria dos Santos Freitas, Wagner Rodrigues de Assis Soares, Sérgio Siqueira, et al. (+4)
121 [GO] 2021―Jan―10 Current Evidence of Interleukin-6 Signaling Inhibitors in Patients With COVID-19: A Systematic Review and Meta-Analysis Qi Han, Mingyue Guo, Yue Zheng, Ying Zhang, Yanshan De, Changchang Xu, et al. (+7)
122 [GO] 2021―Jan―10 Commentary: Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report Christopher E. Rudd
123 [GO] 2021―Jan―07 Hydroxychloroquine as a Chemoprophylactic Agent for COVID-19: A Clinico-Pharmacological Review Mudit Agarwal, Piyush Ranjan, Upendra Baitha, Ankit Mittal
124 [GO] 2020―Dec―28 Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic Giulio Cavalli, Nicola Farina, Corrado Campochiaro, Giacomo De Luca, Emanuel Della-Torre, Alessandro Tomelleri, Lorenzo Dagna
125 [GO] 2020―Dec―23 Case Report: Central Retinal Artery Occlusion in a COVID-19 Patient Andrea Montesel, Claudio Bucolo, Victoria Mouvet, Emmanuelle Moret, Chiara M. Eandi
126 [GO] 2020―Dec―21 D-Dimer as a Prognostic Indicator in Critically Ill Patients Hospitalized With COVID-19 in Leishenshan Hospital, Wuhan, China Jinpeng Li, Zeming Liu, Gaosong Wu, Meilin Yi, Yongfeng Chen, Kun Li, et al. (+5)
127 [GO] 2020―Dec―21 COVID-19 Incidence in Patients With Immunomediated Inflammatory Diseases: Influence of Immunosuppressant Treatments Natalia Soldevila-Domenech, Laura Tío, Jone Llorente-Onaindia, Elena Martín-García, Pau Nebot, Rafael de la Torre, et al. (+3)
128 [GO] 2020―Dec―18 COVID-19 Disease and Vitamin D: A Mini-Review Mohamed Said Boulkrane, Victoria Ilina, Roman Melchakov, Julia Fedotova, Filippo Drago, Lucia Gozzo, et al. (+3)
129 [GO] 2020―Dec―14 Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives Cheng-Wei Yang, Yue-Zhi Lee, Hsing-Yu Hsu, Jia-Tsrong Jan, Yi-Ling Lin, Sui-Yuan Chang, et al. (+15)
130 [GO] 2020―Dec―14 A New Crystal Form of the SARS-CoV-2 Receptor Binding Domain: CR3022 Complex-An Ideal Target for In-Crystal Fragment Screening of the ACE2 Binding Site Surface Charlie Nichols, Joseph Ng, Annika Keshu, Franca Fraternali, Gian F. De Nicola
131 [GO] 2020―Dec―11 Alpha-1 Antitrypsin for COVID-19 Treatment: Dual Role in Antiviral Infection and Anti-Inflammation Chengliang Yang, Shaf Keshavjee, Mingyao Liu
132 [GO] 2020―Dec―11 Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm Michel Desjarlais, Maëlle Wirth, Isabelle Lahaie, Pakiza Ruknudin, Pierre Hardy, Alain Rivard, Sylvain Chemtob
133 [GO] 2020―Dec―11 SARS-CoV-2 Spike-Heat Shock Protein A5 (GRP78) Recognition may be Related to the Immersed Human Coronaviruses Abdo A. Elfiky
134 [GO] 2020―Dec―10 Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review Giuliano Lo Bianco, Santi Di Pietro, Emilia Mazzuca, Aurelio Imburgia, Luca Tarantino, Giuseppe Accurso, et al. (+5)
135 [GO] 2020―Dec―09 Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and Thromboembolism Mohamed Abu-Farha, Salman Al-Sabah, Maha M. Hammad, Prashantha Hebbar, Arshad Mohamed Channanath, Sumi Elsa John, et al. (+8)
136 [GO] 2020―Dec―07 Hydroxychloroquine in COVID-19 Patients: Pros and Cons Nour K. Younis, Rana O. Zareef, Sally N. Al Hassan, Fadi Bitar, Ali H. Eid, Mariam Arabi
137 [GO] 2020―Dec―03 Hydroxychloroquine as Prophylaxis for COVID-19: A Review Manuela Monti, Bernadette Vertogen, Carla Masini, Caterina Donati, Claudia Lilli, Chiara Zingaretti, et al. (+8)
138 [GO] 2020―Dec―03 Perspectives in Peptide-Based Vaccination Strategies for Syndrome Coronavirus 2 Pandemic Concetta Di Natale, Sara La Manna, Ilaria De Benedictis, Paola Brandi, Daniela Marasco
139 [GO] 2020―Nov―30 Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap Lucia Gozzo, Laura Longo, Daniela Cristina Vitale, Filippo Drago
140 [GO] 2020―Nov―30 A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China Nan Zhang, Nannan Shi, Siyu Li, Guoxiu Liu, Yonglong Han, Li Liu, et al. (+25)
141 [GO] 2020―Nov―30 Rationale for COVID-19 Treatment by Nebulized Interferon-β-1b-Literature Review and Personal Preliminary Experience Aurélien Mary, Lucie Hénaut, Pierre Yves Macq, Louise Badoux, Arnaud Cappe, Thierry Porée, et al. (+3)
142 [GO] 2020―Nov―26 Possible Role of Adenosine in COVID-19 Pathogenesis and Therapeutic Opportunities Jonathan D. Geiger, Nabab Khan, Madhuvika Murugan, Detlev Boison
143 [GO] 2020―Nov―26 Deciphering the Pharmacological Mechanisms of Ma Xing Shi Gan Decoction against COVID-19 through Integrating Network Pharmacology and Experimental Exploration Qianqian Li, Chen Bai, Ruocong Yang, Weiying Xing, Xiaohan Pang, Siying Wu, et al. (+4)
144 [GO] 2020―Nov―26 Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches Federica Mannino, Alessandra Bitto, Natasha Irrera
145 [GO] 2020―Nov―25 An Evaluation of Traditional Persian Medicine for the Management of SARS-CoV-2 Roodabeh Bahramsoltani, Roja Rahimi
146 [GO] 2020―Nov―20 Neuronal and Cerebrovascular Complications in Coronavirus Disease 2019 Mudasir S. Andrabi, Shaida A. Andrabi
147 [GO] 2020―Nov―20 Rational Drug Repurposing: Focus on Lysosomotropism, Targets in Disease Process, Drug Profile, and Pulmonary Tissue Accumulation in SARS-CoV-2 Infection/COVID-19 Markus Blaess, Lars Kaiser, Oliver Sommerfeld, Simone Rentschler, René Csuk, Hans-Peter Deigner
148 [GO] 2020―Nov―19 Autophagy Modulation in Lymphocytes From COVID-19 Patients: New Therapeutic Target in SARS-COV-2 Infection Marta Vomero, Cristiana Barbati, Tania Colasanti, Alessandra Ida Celia, Mariangela Speziali, Federica Maria Ucci, et al. (+3)
149 [GO] 2020―Nov―18 Phytochemicals: Potential Therapeutic Interventions Against Coronavirus-Associated Lung Injury Mohammad Bagher Majnooni, Sajad Fakhri, Yalda Shokoohinia, Narges Kiyani, Katrina Stage, Pantea Mohammadi, et al. (+3)
150 [GO] 2020―Nov―17 A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs Po-Lin Chen, Nan-Yao Lee, Cong-Tat Cia, Wen-Chien Ko, Po-Ren Hsueh
151 [GO] 2020―Nov―13 Computational Studies of Hydroxychloroquine and Chloroquine Metabolites as Possible Candidates for Coronavirus (COVID-19) Treatment Niteen A. Vaidya, Renu Vyas
152 [GO] 2020―Nov―09 Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy? José Miguel Vela
153 [GO] 2020―Nov―09 Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review Qin Qiu, Yuge Huang, Xiaohua Liu, Fangfang Huang, Xiaoling Li, Liao Cui, et al. (+2)
154 [GO] 2020―Nov―06 Challenges for Drug Repurposing in the COVID-19 Pandemic Era Janet Sultana, Salvatore Crisafulli, Flic Gabbay, Elizabeth Lynn, Saad Shakir, Gianluca Trifirò
155 [GO] 2020―Nov―06 Celebrex Adjuvant Therapy on Coronavirus Disease 2019: An Experimental Study Wenxin Hong, Yan Chen, Kai You, Shenglin Tan, Feima Wu, Jiawang Tao, et al. (+12)
156 [GO] 2020―Nov―06 Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019 Prakash Nagarkatti, Kathryn Miranda, Mitzi Nagarkatti
157 [GO] 2020―Oct―29 Targeting Macrophages as a Therapeutic Option in Coronavirus Disease 2019 Maria Gracia-Hernandez, Eduardo M. Sotomayor, Alejandro Villagra
158 [GO] 2020―Oct―29 Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments Nabab Khan, Xuesong Chen, Jonathan D. Geiger
159 [GO] 2020―Oct―28 Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs in the Treatment for COVID-19 Hongwei Peng, Zhangren Chen, Yunyun Wang, Simei Ren, Tiantian Xu, Xin Lai, et al. (+9)
160 [GO] 2020―Oct―28 Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements Giorgio Frega, Andrea Palloni, Giuseppe Di Pasquale, Gioconda Saccoccio, Alessandro Rizzo, Elisabetta Poluzzi, et al. (+2)
161 [GO] 2020―Oct―22 Prognostic Value of Pro-Inflammatory Neutrophils and C-Reactive Protein in Cancer Patient With Coronavirus Disease 2019: A Multi-Center, Retrospective Study Bo Zhang, Yuanhang Yu, Shawna Herbet, Yue Zhang, Jianhua Lu, Shihua Liu, et al. (+6)
162 [GO] 2020―Oct―22 Coronavirus-19: Possible Therapeutic Implications of Spironolactone and Dry Extract of Glycyrrhiza glabra L. (Licorice) Decio Armanini, Cristina Fiore, Jens Bielenberg, Chiara Sabbadin, Luciana Bordin
163 [GO] 2020―Oct―16 Tempering Macrophage Plasticity for Controlling SARS-CoV-2 Infection for Managing COVID-19 Disease Devinder Toor, Aklank Jain, Shivani Kalhan, Harmesh Manocha, Vivek Kumar Sharma, Payal Jain, et al. (+2)
164 [GO] 2020―Oct―16 COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management Md. Farhad Hossain, Sharifa Hasana, Abdullah Al Mamun, Md. Sahab Uddin, Mir Imam Ibne Wahed, Sabarni Sarker, et al. (+11)
165 [GO] 2020―Oct―16 Current Prevention of COVID-19: Natural Products and Herbal Medicine Junqing Huang, Gabriel Tao, Jingwen Liu, Junming Cai, Zhongyu Huang, Jia-xu Chen
166 [GO] 2020―Oct―15 Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients Fuxun Yang, Ruiming Yue, Xiaoxiu Luo, Rongan Liu, Xiaobo Huang
167 [GO] 2020―Oct―14 Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity-Opportunity for Repurposed Chemotherapy of COVID-19 Infection Maryam S. Al-Motawa, Hafsa Abbas, Patrick Wijten, Alberto de la Fuente, Mingzhan Xue, Naila Rabbani, Paul J. Thornalley
168 [GO] 2020―Oct―09 Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease Chih-Chao Chiang, Michal Korinek, Wei-Jen Cheng, Tsong-Long Hwang
169 [GO] 2020―Oct―08 Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients Vincenzo Russo, Andreina Carbone, Filiberto Fausto Mottola, Rosa Mocerino, Raffaele Verde, Emilio Attena, et al. (+6)
170 [GO] 2020―Oct―08 “Fei Yan No. 1” as a Combined Treatment for COVID-19: An Efficacy and Potential Mechanistic Study Zhongzhu Ai, Shanshan Zhou, Weinan Li, Mengfan Wang, Linqun Wang, Gangming Hu, et al. (+7)
171 [GO] 2020―Oct―07 COVID-19 Genetic and Environmental Risk Factors: A Look at the Evidence Hana Abdelzaher, Basma M. Saleh, Hebatalla A. Ismail, Marwa Hafiz, Macy Abou Gabal, Miranda Mahmoud, et al. (+4)
172 [GO] 2020―Oct―07 Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness? Piero Sestili, Carmela Fimognari
173 [GO] 2020―Oct―07 Positive RT-PCR Test Results in 420 Patients Recovered From COVID-19 in Wuhan: An Observational Study Shaobin He, Jiaxing Tian, Xiaodong Li, Yana Zhou, Mingzhong Xiao, Ying Zhang, et al. (+19)
174 [GO] 2020―Oct―06 Available Compounds With Therapeutic Potential Against COVID-19: Antimicrobial Therapies, Supportive Care, and Probable Vaccines Rajnish Kumar, Janmejai Kumar Srivastava, Rachana Singh, Mohammed Haris Siddiqui, Rasha A. Mansouri, Jawaher A. Abdulhakim, et al. (+4)
175 [GO] 2020―Oct―02 Mapping Evidence of Pharmacy Services for COVID-19 in China Zhan-Miao Yi, Yang Hu, Guan-Ru Wang, Rong-Sheng Zhao
176 [GO] 2020―Sep―25 Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19) Surjeet Verma, Danielle Twilley, Tenille Esmear, Carel B. Oosthuizen, Anna-Mari Reid, Marizé Nel, Namrita Lall
177 [GO] 2020―Sep―25 The Important Role of Volatile Components From a Traditional Chinese Medicine Dayuan-Yin Against the COVID-19 Pandemic Xiao-rui Zhang, Ting-na Li, Yuan-yuan Ren, Yi-jia Zeng, Hong-yang Lv, Jin Wang, Qin-wan Huang
178 [GO] 2020―Sep―25 The Regulatory Challenges for Drug Repurposing During the Covid-19 Pandemic: The Italian Experience Lucia Gozzo, Laura Longo, Daniela Cristina Vitale, Filippo Drago
179 [GO] 2020―Sep―24 COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy? Dâmaris Silveira, Jose Maria Prieto-Garcia, Fabio Boylan, Omar Estrada, Yris Maria Fonseca-Bazzo, Claudia Masrouah Jamal, et al. (+4)
180 [GO] 2020―Sep―18 Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study Jie Fang, Hui Li, Wei Du, Ping Yu, Ying-Yun Guan, Shi-Yu Ma, et al. (+4)
181 [GO] 2020―Sep―17 Pathophysiology and Potential Therapeutic Candidates for COVID-19: A Poorly Understood Arena Arghadip Samaddar, Malika Grover, Vijaya Lakshmi Nag
182 [GO] 2020―Sep―16 In Silico Prediction of Molecular Targets of Astragaloside IV for Alleviation of COVID-19 Hyperinflammation by Systems Network Pharmacology and Bioinformatic Gene Expression Analysis Chenliang Ge, Yan He
183 [GO] 2020―Sep―16 Outcomes and Laboratory and Clinical Findings of Asthma and Allergic Patients Admitted With Covid-19 in a Spanish University Hospital Jesús Miguel García-Menaya, Concepción Cordobés-Durán, Juan Francisco Rangel-Mayoral, Elena García-Martín, José A. G. Agúndez
184 [GO] 2020―Sep―16 Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications: A Review of the Current Evidence Filippo Drago, Lucia Gozzo, Li Li, Andrea Stella, Benilde Cosmi
185 [GO] 2020―Sep―15 Systems Pharmacology and Verification of ShenFuHuang Formula in Zebrafish Model Reveal Multi-Scale Treatment Strategy for Septic Syndrome in COVID-19 Tengwen Liu, Yuhong Guo, Jingxia Zhao, Shasha He, Yunjing Bai, Ning Wang, et al. (+3)
186 [GO] 2020―Sep―15 The Potential of Antiviral Peptides as COVID-19 Therapeutics Arun Suria Karnan Mahendran, Yin Sze Lim, Chee-Mun Fang, Hwei-San Loh, Cheng Foh Le
187 [GO] 2020―Sep―15 Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives Chandan Sarkar, Milon Mondal, Muhammad Torequl Islam, Miquel Martorell, Anca Oana Docea, Alfred Maroyi, et al. (+2)
188 [GO] 2020―Sep―11 Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future Olayinka O. Ogunleye, Debashis Basu, Debjani Mueller, Jacqueline Sneddon, R. Andrew Seaton, Adesola F. Yinka-Ogunleye, et al. (+66)
189 [GO] 2020―Sep―11 Research Progress on Main Symptoms of Novel Coronavirus Pneumonia Improved by Traditional Chinese Medicine Chuan-hong Luo, Le-le Ma, Hui-min Liu, Wei Liao, Run-chun Xu, Zhi-min Ci, et al. (+3)
190 [GO] 2020―Sep―10 Clinical Studies on the Treatment of Novel Coronavirus Pneumonia With Traditional Chinese Medicine-A Literature Analysis Zhihuan Zhou, Ning Gao, Yumeng Wang, Pengcheng Chang, Yi Tong, Shufei Fu
191 [GO] 2020―Sep―09 Age-Dependent Assessment of Genes Involved in Cellular Senescence, Telomere, and Mitochondrial Pathways in Human Lung Tissue of Smokers, COPD, and IPF: Associations With SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 Axis Krishna P. Maremanda, Isaac K. Sundar, Dongmei Li, Irfan Rahman
192 [GO] 2020―Sep―09 Efficacy and Safety of Corticosteroid Treatment in Patients With COVID-19: A Systematic Review and Meta-Analysis Wenwen Cheng, Yufeng Li, Liyan Cui, Ying Chen, Sharui Shan, Duan Xiao, et al. (+3)
193 [GO] 2020―Sep―04 Montelukast Drug May Improve COVID-19 Prognosis: A Review of Evidence Jean Barré, Jean-Marc Sabatier, Cédric Annweiler
194 [GO] 2020―Sep―04 Potential Application of Drosophila melanogaster as a Model Organism in COVID-19-Related Research Firzan Nainu, Dini Rahmatika, Talha Bin Emran, Harapan Harapan
195 [GO] 2020―Sep―03 Skin Hyperpigmentation in Coronavirus Disease 2019 Patients: Is Polymyxin B the Culprit? Cuicui Lu, Ning Hou
196 [GO] 2020―Sep―02 Coronavirus Disease 2019 Related Clinical Studies: A Cross-Sectional Analysis Lin-Lu Ma, Xuan Yin, Bing-Hui Li, Jia-Yu Yang, Ying-Hui Jin, Di Huang, et al. (+5)
197 [GO] 2020―Aug―28 Immunosuppressive Drugs and COVID-19: A Review Tessa S. Schoot, Angèle P. M. Kerckhoffs, Luuk B. Hilbrands, Rob J. van Marum
198 [GO] 2020―Aug―28 Mitochondria Targeted Viral Replication and Survival Strategies-Prospective on SARS-CoV-2 Priya Gatti, Hema Saranya Ilamathi, Kiran Todkar, Marc Germain
199 [GO] 2020―Aug―27 Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report Carlos Spuch, Marta López-García, Tania Rivera-Baltanás, Daniela Rodrígues-Amorím, José M. Olivares
200 [GO] 2020―Aug―27 Quality Assessment of the Chinese Clinical Trial Protocols Regarding Treatments for Coronavirus Disease 2019 Jiaxing Zhang, Yiling Lu, Joey Sum-wing Kwong, Xiaosi Li, Wenyi Zheng, Rui He
201 [GO] 2020―Aug―27 Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019 Chunsheng Zhu, Bao Sun, Xiaochuan Zhang, Bing Zhang
202 [GO] 2020―Aug―26 SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus Simona Iacob, Diana Gabriela Iacob
203 [GO] 2020―Aug―21 Evaluation of Remote Pharmacist-Led Outpatient Service for Geriatric Patients on Rivaroxaban for Nonvalvular Atrial Fibrillation During the COVID-19 Pandemic Xiaoye Li, Chengchun Zuo, Wenjing Lu, Ye Zou, Qing Xu, Xiaoyu Li, Qianzhou Lv
204 [GO] 2020―Aug―21 The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review Lucia Gozzo, Pierluigi Viale, Laura Longo, Daniela Cristina Vitale, Filippo Drago
205 [GO] 2020―Aug―20 Harnessing Memory NK Cell to Protect Against COVID-19 Saeede Soleimanian, Ramin Yaghobi
206 [GO] 2020―Aug―19 Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19 Rudra P. Saha, Ashish Ranjan Sharma, Manoj K. Singh, Saikat Samanta, Swarnav Bhakta, Snehasish Mandal, et al. (+3)
207 [GO] 2020―Aug―14 COVID-19 Usurps Host Regulatory Networks Colleen S. Curran, Donna R. Rivera, Jeffrey B. Kopp
208 [GO] 2020―Aug―13 A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes Colin D. Funk, Ali Ardakani
209 [GO] 2020―Aug―13 COVID-19 Therapeutic Options Under Investigation Malak Kaddoura, Malak AlIbrahim, Ghina Hijazi, Nadia Soudani, Amani Audi, Habib Alkalamouni, et al. (+3)
210 [GO] 2020―Aug―12 Corticosteroid Use in the Treatment of COVID-19: A Multicenter Retrospective Study in Hunan, China Yiming Ma, Huihui Zeng, Zijie Zhan, Huanhuan Lu, Zihang Zeng, Chenjie He, et al. (+13)
211 [GO] 2020―Aug―11 Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients Pasquale Paolisso, Luca Bergamaschi, Emanuela Concetta D’Angelo, Francesco Donati, Maddalena Giannella, Sara Tedeschi, et al. (+8)
212 [GO] 2020―Aug―07 Medicinal Plants as Sources of Active Molecules Against COVID-19 Bachir Benarba, Atanasio Pandiella
213 [GO] 2020―Aug―07 DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications? Inés Valencia, Concepción Peiró, Óscar Lorenzo, Carlos F. Sánchez-Ferrer, Jürgen Eckel, Tania Romacho
214 [GO] 2020―Aug―05 DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19-A Therapeutic Approach of Choice in Type 2 Diabetic Patients? Andrija Smelcerovic, Gordana Kocic, Mihajlo Gajic, Katarina Tomovic, Vukica Djordjevic, Dobrila Stankovic-Djordjevic, Marko Anderluh
215 [GO] 2020―Jul―31 Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use Yan Chen, TaiPeng Shen, LiJun Zhong, ZhiXi Liu, XinWei Dong, TingWenLi Huang, et al. (+2)
216 [GO] 2020―Jul―29 Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention John P. Hussman
217 [GO] 2020―Jul―29 Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients Giorgio Zauli, Veronica Tisato, Paola Secchiero
218 [GO] 2020―Jul―17 Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19 Zeming Liu, Jinpeng Li, Danyang Chen, Rongfen Gao, Wen Zeng, Sichao Chen, et al. (+7)
219 [GO] 2020―Jul―17 Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China Wei Zhuang, Zheng Fan, Yanqi Chu, Haizheng Wang, Ying Yang, Li Wu, et al. (+6)
220 [GO] 2020―Jul―16 The Folate Concentration and/or Folic Acid Metabolites in Plasma as Factor for COVID-19 Infection Jesus Acosta-Elias, Ricardo Espinosa-Tanguma
221 [GO] 2020―Jul―15 Selective Estrogen Receptor Modulators in COVID-19: A Possible Therapeutic Option? Alba Calderone, Francesco Menichetti, Ferruccio Santini, Luciano Colangelo, Ersilia Lucenteforte, Vincenzo Calderone
222 [GO] 2020―Jul―14 No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study Yin-Qiu Huang, Sheng-Quan Tang, Xiao-Lei Xu, Yan-Ming Zeng, Xiao-Qing He, Yao Li, et al. (+9)
223 [GO] 2020―Jul―10 Pathological Aspects of COVID-19 as a Conformational Disease and the Use of Pharmacological Chaperones as a Potential Therapeutic Strategy Tomohiko Aoe
224 [GO] 2020―Jul―09 BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine? Siya Kamat, Madhuree Kumari
225 [GO] 2020―Jul―02 Turning the Tide: Natural Products and Natural-Product-Inspired Chemicals as Potential Counters to SARS-CoV-2 Infection Zhonglei Wang, Liyan Yang
226 [GO] 2020―Jun―24 Pharmacotherapics Advice in Guidelines for COVID-19 Zhang-Ren Chen, Ying Zhou, Jin Liu, Hong-Wei Peng, Jian Zhou, Hai-Li Zhong, et al. (+4)
227 [GO] 2020―Jun―24 Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy Ying Wang, Yang Zhang, Qian Yu, Kun Zhu
228 [GO] 2020―Jun―19 Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19 Maria Laura Belladonna, Ciriana Orabona
229 [GO] 2020―Jun―19 A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic Colin D. Funk, Craig Laferrière, Ali Ardakani
230 [GO] 2020―Jun―12 New Strategy for COVID-19: An Evolutionary Role for RGD Motif in SARS-CoV-2 and Potential Inhibitors for Virus Infection Shijia Yan, Haixia Sun, Xianzhang Bu, Guohui Wan
231 [GO] 2020―Jun―05 Repositioning Chromones for Early Anti-inflammatory Treatment of COVID-19 Piero Sestili, Vilberto Stocchi
232 [GO] 2020―Jun―05 Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19 Teluguakula Narasaraju, Benjamin M. Tang, Martin Herrmann, Sylviane Muller, Vincent T. K. Chow, Marko Radic
233 [GO] 2020―Jun―05 Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study Valentina Giudice, Pasquale Pagliano, Alessandro Vatrella, Alfonso Masullo, Sergio Poto, Benedetto Maria Polverino, et al. (+10)
234 [GO] 2020―May―29 An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy? Giuseppe Terrazzano, Valentina Rubino, Anna Teresa Palatucci, Angela Giovazzino, Flavia Carriero, Giuseppina Ruggiero
235 [GO] 2020―May―26 Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19? Mekonnen Sisay
236 [GO] 2020―May―01 The Zebrafish Disease and Drug Screening Model: A Strong Ally Against Covid-19 Jorge Galindo-Villegas


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.013 sec